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Abstract
Health data are often not symmetric to be adequately modeled through the usual normal distribu-
tions; most of them exhibit skewed patterns. They can indeed be modeled better through the larger
family of skew-normal distributions covering both skewed and symmetric cases. However, the existing
likelihood based inference, that is routinely performed in these cases, is extremely non-robust against
data contamination/outliers. Since outliers are not uncommon in complex real-life experimental datasets,
a robust methodology automatically taking care of the noises in the data would be of great practical
value to produce stable and more precise research insights leading to better policy formulation. In this
paper, we develop a class of robust estimators and testing procedures for the family of skew-normal
distributions using the minimum density power divergence approach with application to health data.
In particular, a robust procedure for testing of symmetry is discussed in the presence of outliers. Two
efficient computational algorithms are discussed. Besides deriving the asymptotic and robustness theory
for the proposed methods, their advantages and utilities are illustrated through simulations and a couple
of real-life applications for health data of athletes from Australian Institute of Sports and AIDS clinical
trial data.
Key words: Skew normal (SN) distribution; Robust minimum density power divergence estimation;
Wald-type test; Test for symmetry; Genetic algorithm; Influence function.
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1 Introduction
Health science is an integral part of medical research where the objective is to improve the quality of
human (as well as animal) health through appropriate scientific insight generation and necessary policy
implementation. The backbone of health science research is the efficient analyses of heath data obtained
from several designed or observational medical experiments or surveys with appropriate target questions in
mind. The innovations and insights generated from such analyses are essential in medical research to develop
cures to any sort of illness and ensure better health quality; they are also important for any country (and
even globally) to prepare appropriate health policies.
Often, the conventional statistical distribution used in modeling different kinds of health data is the bell-
shaped and symmetric normal distribution. Although it works for some health measurements like height or
weight of patients, etc., most health data, specially those measured on some clinical metrics, often exhibit
empirical skewness so that the conventional normal distribution can not be used to model/analyze them [?
]. Among several possible parametric distributions to model skewed data, possibly the most popular one is
the Azzalini-type Skew Normal (SN) distribution family [1–4] which also covers the usual symmetric normal
distribution as a special case; see Figure 1 for a wide variety of distributional shapes (densities) of the SN
distribution obtained by varying the shape parameter. Lately, this SN distribution has been successfully
applied to model and analyze different types of recent biomedical data [5? –23]. In this paper, we focus on
the SN distribution family for modeling data from different health measurements under one umbrella and
on the inference using the estimators of the corresponding SN parameters.
Figure 1: Probability densities of SN distribution with parameters µ = 0, σ = 1 and different values of γ.
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The SN distribution is defined in terms of three parameters, namely the location parameter µ ∈ R, the
scale parameter σ ∈ R+ and the skewness parameter γ ∈ R, and is denoted by SN(µ, σ, γ). In particular, if
µ = 0 and σ = 1, it is referred to as the standard SN distribution and is denoted by SN(γ). The probability
density function (pdf) and the cumulative distribution function (cdf) of the SN(µ,σ,γ) distribution are given,
respectively, as
fθ(x) =
2
σ
φ
(
x− µ
σ
)
Φ
(
γ
x− µ
σ
)
, x ∈ R, (1)
Fθ(x) = Φ
(
x− µ
σ
)
− 2T
(
x− µ
σ
, γ
)
, x ∈ R, (2)
where θ =
(
µ, σ, γ
)T
is the vector of unknown parameters, φ and Φ are the pdf and the cdf of the standard
normal distribution, respectively, and T (h, a) is Owen’s function defined as
T (h, a) =
1
2pi
∫ a
0
e−
h2
2 (1+x
2)
1 + x2
dx, h, a ∈ R.
The mean, variance and skewness (γ1) of a random variable X having SN(µ,σ,γ) distribution are given by
E(X) = µ+σδ
√
2
pi , V ar(X) = σ
2
(
1− 2δ2pi
)
, with δ = γ(1 + γ2)−1/2, and γ1 =
(4−pi)γ3
2(pi2+(
pi
2−1)γ2)
3/2 . Clearly, the
SN distribution is positively and negatively skewed according to the sign of the parameter γ; see Figure 1. At
the particular case γ = 0, the SN distribution SN(µ, σ, 0) has skewness zero and coincides with symmetric
normal distribution, N(µ, σ2), having mean µ and variance σ2.
Given a random sample X1, . . . , Xn from a skewed population, we can fit the SN distribution by esti-
mating the parameters θ =
(
µ, σ, γ
)T
based on the observed data and the subsequent inference can be done
based upon these estimates. The usual method of estimation under SN model is the maximum likelihood
estimator (MLE) which is asymptotically the most efficient at the model. But, a major drawback of the
MLE is its extreme non-robust nature against data contaminations, outliers or model misspecifications; this
further makes all the MLE based inference highly unstable yielding incorrect insights. However, it is not
unusual to have some outlying observations in modern complex datasets due to several external or erroneous
factors/activities. Hence, a robust inference procedure automatically taking care of the noises (outliers)
in the data would be of great practical value to produce stable and more precise research insights leading
to better policy formulation. To further motivate our work in the context of health data analyses, let us
consider the following real data example.
3
A Motivating Example (AIS data):
We consider the data on health measurements of 706 Australian athletes from 12 different sports which were
collected at the Australian Institute of Sports (AIS) in 1990 by Telford and Cunningham [24] to investigate
the relationships of the five routine hematological measures, namely the hemoglobin concentration (HC),
hematocrit (H), red cell count (RCC), white cell count (WCC) and plasma ferritin concentration (PFC) in
the blood of these athletes with their height (Ht), weight (Wt) and the sports type. These measurements are
recorded on 1604 occasions from each athletes based on the blood samples collected from their forearm vein
amidst periods of moderate to intense training but at least 6 hours after a training session. Some important
derived health measurements like body-mass index (BMI) and lean body mass (LBM) are also reported.
The data were later used by several researchers in different statistical inference problems; in particular, few
of them fitted the SN distribution with MLE but only to a few measurements and/or a part of the data
[21, 25].
Let us here consider eight important health measurements, namely HC, RCC, WCC, PFC, BMI, LBM,
Ht and Wt, from 202 athletes as available in the R package ‘DAAG ’, and plot the corresponding histograms
and box-plots in Figure 2. From the figure it may be seen that several of these variables exhibit clearly skewed
patterns. For example, RCC, WCC, PFC, BMI and LBM have between mild to prominently pronounced
positive skewness. Ht, on the other hand, has negative skewness. The other two, HC and Wt are more
difficult to judge visually. The SN family of distributions, therefore, can be used to model all these health
measurements. However, in all the cases, the respective box-plots reveal one or more outlying values which
makes the MLE and the associated inference highly unstable. The MLE based fits are also shown in the
figures along with the histogram, which clearly show the inability of the MLE to adequately model the bulk
of the data due to the presence of few outlying points. In particular, the fitted distributions (by MLE) have a
somewhat different mode and skewness compared to the majority of the empirical data for the measurements
HC, PFC, BMI, LBM and Ht due to strong outlier effects. We have also computed the MLE after removing
the outliers identified through respective box plots which are presented in Table 6 along with the full data
MLE (and their standard errors); the changes in the estimates due to the presence of outliers are quite
drastic in most cases. Although there is only one outlier in HC, its effect is quite dramatic in that the
deletion of this single observation leads to a reversal in the sign of γ; the MLE of γ for the full data (with
the outlier) is 0.9655 and any standard testing procedure based on the MLE will reject the hypothesis of
negative skewness of this distribution although the removal of this single outlier produces a value of −1.7941
as the MLE of γ. The MLE of σ increases drastically for PFC, BMI and Wt due to the presence of outliers
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(73.8403, 4.1327 and 17.6825, respectively, for the full data compared to the corresponding MLEs 57.6705,
2.3489, and 13.0243 for the outlier deleted data) and hence results in an inadequate fit for their mode. These
examples clearly illustrate the non-robust and unstable nature of the MLE based inference under the SN
distribution in the presence of outliers leading to contradictory insights! 
(a) Hemoglobin Conc. (HC) (b) Red Cell Count (RCC) (c) White Cell Count (WCC) (d) Plasma Ferritin Conc. (PFC)
(e) Body Mass Index (BMI) (f) Lean Body Mass (LBM) (g) Height (Ht) (h) Weight (Wt)
Figure 2: Histograms and Box-plots of different Health indicator variables from the AIS Data. The SN
distribution fitted by the MLE is also shown along with the histograms.
However, the use of SN distribution for modeling the health measurements and its skewness is indeed
justifiable through its distributional structure as well as technically from the concept of selective sampling
[3, 26]. For a brief explanation, suppose that we want to model a health measurement variable U1, which is
assumed to be standardized for simplicity. In most cases, health data are collected from a random sample
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of an appropriately defined subpopulation satisfying a minimum health standard; in the above example of
AIS data all observations are collected from trained athletes who are known to be healthier than others
(in some appropriate health measurement scale). Suppose such subpopulation is defined in terms of the
condition U0 > τ for a population random variable U0; without loss of generality we may assume U0 to
be also standardized. Assume τ = 0, U0 is normally distributed and has a correlation ρ with U1. Then,
even if U1 is normally distributed in the population, its distribution over the subpopulation, i..e, conditional
distribution given U0 > 0 is indeed SN(γ) with γ = ρ(1 − ρ2)−1/2. It can only be symmetric if the target
variable is uncorrelated with sub-population defining variable U0.
Therefore the SN distribution is inevitable in health data analyses and it is the MLE which makes the
ultimate inference erroneous under data contamination. Therefore, it is important to develop an appropriate
robust inference methodology for the SN distribution family. Unfortunately, little attention has been paid on
this issue in the literature, except for a few discrete attempts for some particular applications only [27–30].
In this paper, we develop a simple yet highly efficient robust inference procedure for the SN distribution
that can even be generalized to any complex inference problem associated with skewed data quite easily.
Among several approaches to robust inference, we consider the minimum distance approach to estimate
the parameters of the SN distribution by minimizing an appropriate divergence (distance) measure between
the data and the model density. In particular, we consider the density power divergence (DPD) measure
[31] which has lately been extremely popular because of generating extremely robust estimators along with
high asymptotic efficiency [32–39]. In this paper, we first define the minimum DPD estimator (MDPDE)
of the parameters of the SN distribution based on a random sample and discuss its asymptotic properties
like consistency and asymptotic normality. Their asymptotic variance can then be consistently estimated to
obtain the standard errors of our proposed estimators and their robustness properties are discussed through
the influence function analysis. Since there are complexity in the computation of the MLE itself for SN
distribution [25], the computation of the MDPDE is also challenging; we have developed an efficient algorithm
for this purpose using the concept of Genetic Algorithm [40]. We next develop a robust Wald-type test based
on the proposed MDPDE along with their asymptotic and robustness properties. The important particular
case of testing the hypothesis of symmetry (γ = 0) under the SN alternatives are discussed in great detail.
The fixed-sample performances of the proposed estimation and testing procedures are illustrated through
extensive simulation studies. Our proposals are then applied to reanalyze the motivating AIS dataset as well
as to analyze data from an AIDS clinical trial for robust inferential insights. Finally the paper ends with
some concluding discussion about our work and its possible future extensions.
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2 The Minimum DPD Estimation for the SN distributions
2.1 Estimating Equation
The DPD family [31] is indexed by a single tuning parameter α ≥ 0, controlling the trade-off between
robustness and efficiency. For two densities g and f , both being absolutely continuous with respect to some
common dominating measure µ, the DPD measure between g and f is defined as
dα(g, f) =
∫ {
f1+α −
(
1 +
1
α
)
gfα +
1
α
g1+α
}
dµ, if α > 0, (3)
d0(g, f) = lim
α↓0
dα(g, f) =
∫
g log
g
f
dµ. (4)
Note that, the DPD at α = 0 is nothing but the well-known Kullback-Leiber divergence (KLD) associated
with the likelihood approach. We need to minimize the DPD measure between the estimated data density and
the postulated model density to obtain the “best fitted” model and the corresponding parameter estimates.
Suppose we have a random sample X1, . . . , Xn from a population having true density g with the associated
distribution function G (with the associated measure µ being the Lebesgue measure). We wish to model
them by the SN distribution having density fθ and distribution function Fθ, which are given in (1) and (2),
respectively. Then, the minimum DPD estimator (MDPDE) of the unknown model parameter θ is to be
obtained by minimizing dα(ĝ, fθ) over the parameter space Θ = R × R+ × R, where ĝ is an estimate of g
based on the observed sample. One major advantage of the DPD measure is that we can avoid estimating
density g by nonparametric smoothing, which often has several complications like bandwidth selection, curse
of dimensionality etc. This is because we can rewrite the form of the DPD from (3) as
dα(g, fθ) =
∫
f1+αθ dµ−
(
1 +
1
α
)∫
fαθ dG+K,
where the last term K = 1α
∫
g1+αdµ is independent of the parameter θ and has no effect in our target
minimization with respect to θ ∈ Θ. Noting that the second term can be estimated just by plugging in the
empirical estimate of G, namely the empirical CDF obtained based on the sample X1, . . . , Xn, the MDPDE
can be obtained by minimizing the simpler objective function
Hn(θ) =
∫
f1+αθ dµ−
(
1 +
1
α
)
1
n
n∑
i=1
fθ(Xi)
α.
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For the present case of SN distribution, using the form of fθ from (1) with µ being the usual Lebesgue
measure, the above MDPDE objective function has the form
Hn(θ) = Hn(µ, σ, γ) =
∫ ∞
−∞
(
2
σ
)α+1
φ
(
x− µ
σ
)α+1
Φ
(
γ
x− µ
σ
)α+1
dx
−
(
1 +
1
α
)
1
n
n∑
i=1
(
2
σ
)α
φ
(
xi − µ
σ
)α
Φ
(
γ
xi − µ
σ
)α
. (5)
Note that, the integral part of the objective function (5) do not have a tractable closed-form expression, and
hence we need to compute it numerically during the simultaneous minimization of Hn(µ, σ, γ) with respect to
the three parameters (µ, σ, γ). By standard differentiation, we get the estimating equations of our MDPDE
as given by
1
n
n∑
i=1
uθ(Xi)
(
2
σ
)α
φ
(
xi − µ
σ
)α
Φ
(
γ
xi − µ
σ
)α
= ξα(θ), (6)
where uθ(x) =
∂
∂θ log fθ(x) is the score function of the SN distribution and has the form
uθ(x) =
(
x− µ
σ2
− γφ
(
γ x−µσ
)
σΦ
(
γ x−µσ
) , (x− µ)2
σ3
− γ (x− µ)
σ2
φ
(
γ x−µσ
)
Φ
(
γ x−µσ
) − 1
σ
,
(x− µ)
σ
φ
(
γ x−µσ
)
Φ
(
γ x−µσ
))T , (7)
and
ξα(θ) =
∫
uθ(x)fθ(x)
α+1dx =
(
ξ(1)α (θ) ξ
(2)
α (θ) ξ
(3)
α (θ)
)T
. (8)
Clearly there is no closed form solution of the above MDPDE estimating equations in (6) and we need to
solve them numerically in order to obtain the MDPDEs based on a given sample. An efficient method for
the computation of the MDPDE is dicussed later in Section 3.
It is important to note that the MDPDE is indeed an M-estimator, since its estimating equation can be
written in the form
∑
i ψ(Xi,θ) = 0 for a model based ψ-function; see Equation (6) to identify it. Further,
as α→ 0, the MDPDE objective function in (5) satisfies [Hn(θ) + 1α]→ 1−the log-likelihood function, and
the MDPDE estimating equation in (6) coincides with the usual score equation leading to the MLE. Hence,
the MDPDEs at α > 0 can be thought of as a generalization of the MLE to achieve greater robustness
against data contamination.
8
2.2 Asymptotic Efficiency and Standard Error
The asymptotic distribution of the MDPDE for the present case of the SN distribution can easily be obtained
from its general theory or the M-estimation theory. In particular, the minimum DPD estimators are
√
n-
consistent and asymptotically normal. At a given α ≥ 0, if the corresponding MDPDE obtained based on a
random sample of size n is denoted by θ̂α,n, and the true parameter value is θ0, we have
√
n
(
θ̂α,n − θ0
) D→N3 (03,Σα(θ)) ,
where 0p is a p-vector with all entries zero and Σα(θ) = Jα(θ)
−1Kα(θ)Jα(θ)−1. Here, for SN distributions
with θ = (µ, σ, γ)T , the 3× 3 matrices Kα(θ) and Jα(θ) are given by
Jα(θ) =
∫
uθ(x)u
T
θ (x)fθ(x)
α+1dx =

N
(11)
α (θ) N
(12)
α (θ) N
(13)
α (θ)
N
(12)
α (θ) N
(22)
α (θ) N
(23)
α (θ)
N
(13)
α (θ) N
(23)
α (θ) N
(33)
α (θ)
 , (9)
Kα(θ) =
∫
uθ(x)u
T
θ (x)fθ(x)
2α+1dx− ξα(θ)ξα(θ)T
=

N
(11)
2α (θ)− ξ(1)α (θ)2 N (12)2α (θ)− ξ(1)α (θ)ξ(2)α (θ) N (13)2α (θ)− ξ(1)α (θ)ξ(3)α (θ)
N
(12)
2α (θ)− ξ(1)α (θ)ξ(2)α (θ) N (22)2α (θ)− ξ(2)α (θ)2 N (23)2α (θ)− ξ(2)α (θ)ξ(3)α (θ)
N
(13)
2α (θ)− ξ(1)α (θ)ξ(3)α (θ) N (23)2α (θ)− ξ(2)α (θ)ξ(3)α (θ) N (33)2α (θ)− ξ(3)α (θ)2
 , (10)
where ξα(θ) and fθ are as defined in (8) and (1), respectively, and
N (11)α (θ) =
∫ ∞
−∞
((
x− µ
σ2
)
− γ
σ
φ
(
γ x−µσ
)
Φ
(
γ x−µσ
))2fθ(x)α+1dx
N (22)α (θ) =
∫ ∞
−∞
((
x− µ)2
σ3
− 1
σ
− γ
(
x− µ)
σ2
φ
(
γ x−µσ
)
Φ
(
γ x−µσ
))2fθ(x)α+1dx
N (33)α (θ) =
∫ ∞
−∞
(
x− µ
σ
φ
(
γ x−µσ
)
Φ
(
γ x−µσ
))2fθ(x)α+1dx
N (12)α (θ) =
∫ ∞
−∞
((
x− µ
σ2
)
− γ
σ
φ
(
γ x−µσ
)
Φ
(
γ x−µσ
))((x− µ)2
σ3
− 1
σ
− γ
(
x− µ)
σ2
φ
(
γ x−µσ
)
Φ
(
γ x−µσ
))fθ(x)α+1dx
N (13)α (θ) =
∫ ∞
−∞
((
x− µ
σ2
)
− γ
σ
φ
(
γ x−µσ
)
Φ
(
γ x−µσ
))(x− µ
σ
φ
(
γ x−µσ
)
Φ
(
γ x−µσ
))fθ(x)α+1dx
N (23)α (θ) =
∫ ∞
−∞
((
x− µ)2
σ3
− 1
σ
− γ
(
x− µ)
σ2
φ
(
γ x−µσ
)
Φ
(
γ x−µσ
))(x− µ
σ
φ
(
γ x−µσ
)
Φ
(
γ x−µσ
))fθ(x)α+1dx.
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Here we can see that the above integrals do not have a closed form, but we can numerically calculate them
to compute the asymptotic variance matrix at different given values of α and θ. Based on these formulas, we
can study the asymptotic relative efficiency (ARE) of the proposed MDPDE which are presented in Table 1
at different values of θ = (µ, σ, γ)T for the SN distribution. Note that, these AREs decrease with increasing
α but the loss in efficiency is not quite significant at small positive α.
Table 1: Asymptotic Relative Efficiency of the MDPDEs of (µ, σ, γ)T in different SN distributions
α
Distribution 0(MLE) 0.05 0.1 0.2 0.3 0.5 0.7 1
SN(0,1,1) µ 100 99.76 98.13 94.77 86.08 77.26 68.19 58.13
σ 100 99.10 95.45 91.40 86.93 76.20 64.70 52.16
γ 100 98.94 95.51 92.42 90.25 84.24 76.18 65.20
SN(0,1,0) µ 100 99.41 98.22 92.81 85.34 77.00 68.92 57.23
σ 100 98.87 96.11 91.09 85.66 74.39 63.91 52.82
γ 100 99.24 98.57 92.86 91.34 83.76 76.82 66.95
SN(0,1,-1) µ 100 99.07 96.48 91.34 85.55 79.75 68.36 58.44
σ 100 98.84 95.37 90.66 84.18 76.68 65.48 54.90
γ 100 98.17 94.96 91.23 89.96 81.19 72.97 65.69
The above asymptotic variance formula can also help us to obtain the standard errors of the MDPDEs
in any practical application. For the MDPDE θ̂α,n = (µ̂α,n, σ̂α,n, γ̂α,n)
T , obtained based on a sample of
size n, its standard errors are given by
√
Σ
(11)
α (θ0)/n,
√
Σ
(22)
α (θ0)/n and
√
Σ
(33)
α (θ0)/n, respectively, where
Σ
(ij)
α (θ) denotes the (i, j)-th element of the asymptotic variance matrix Σα(θ) for i, j = 1, 2, 3. A consistent
estimate of Σα(θ) is given by Σα(θ̂α,n), from which we can easily estimate (consistently) the standard errors
of the MDPDEs of each parameter µ, σ and γ.
2.3 Robustness: Influence Function Analysis
The robustness of an estimator can be theoretically examined through the classical influence function (IF)
analysis [41]. The IF indeed measures the asymptotic (standardized) bias of the estimator caused by an
infinitesimal contamination at a distant contamination point (say y). Therefore, the boundedness of the IF
over the contamination point y restricts the extent of possible bias finitely for the corresponding estimator
indicating its robust nature (sometime also referred to as B-robustness to emphasis the boundedness of bias).
On the other hand, an unbounded IF indicates possible unbounded bias and non-robustness of the estimator.
Further, with similar intuition, the supremum of the absolute IF taken over all possible contamination points
naturally indicates the extent of (bias) robustness of the corresponding estimator.
From the theory of M estimator [41] or that of the general MDPDE [31, 32], one can obtain the influ-
10
ence function of the MDPDE functional, say T α for a tuning parameter α, under the present case of SN
distribution which is given by
IF (y, Tα,θ) = Jα(θ)
−1[uθ(y)fθ(y)α − ξα(θ)], (11)
where ξα and Jα are defined as in (8) and (9), respectively. Now, the form of the SN density fθ in (1) and
the corresponding score function uθ in (7) clearly indicates that the above IF is bounded in y for all α > 0
and unbounded at α = 0. We have presented the IFs of the three parameters (µ, σ, γ) in Figure 3 for different
values of α which clearly illustrate their boundedness for α > 0. This demonstrates the claimed robustness
of the MDPDEs at any α > 0 and the well-known non-robustness of the MLE at α = 0. Additionally we
can clearly observe the redescending nature of the IFs with increasing values of α which, in turn, indicates
the greater extent of robustness with increasing α.
(a) IF for µ (b) IF for σ
(c) IF for γ
Figure 3: Influence functions (IF) of the MDPDEs of the parameters of the SN distribution at SN(0,1,1)
for different α [Blue solid line: α = 0 (MLE); dashed line: α = 0.1; dotted line: α = 0.3; dash-dotted line:
α = 0.5; black solid line: α = 1]
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3 Computation of the MDPDE
In order to compute the MDPDE, we need to minimize the objective function in (5) simultaneously with
respect to the three parameters (µ, σ, γ), or equivalently solve the three estimating equations given in (6).
These are not straightforward numerical exercises due to the complex form of the objective function and
standard numerical procedures like Newton-Raphson algorithm fail. It is indeed also a known problem in
case of the computation of the MLE for the SN distribution as well, for which some advanced numerical
procedures has been tried in the literature. Here, we describe two possible efficient algorithms for the
computation of our MDPDE at any given α > 0.
3.1 Genetic Algorithm
The genetic algorithm (GA) has been successfully applied for the computation of the MLE under the SN
model by [25]. The GA is an useful and appropriately designed randomized search technique to find exact or
approximate solutions in an optimization problem. Although John Holland first introduced this algorithm
in 1960, it has become popular lately through the works of David Goldberg and others with divergent
applications [40, 42]. The name unsurprisingly came from its structural similarity with genetic mutations and
crossover across generations following the basic principle of the Darwinian Theory of “Survival of the Fittest”.
For an optimization problem, we need to consider an appropriate fitness function (often the objective function
itself) which produce the fitness value of each possible (candidate) solution under the objective criterion.
Then, in brief, the GA starts with an initial set of candidate solutions (chromosomes) and iterates over the
subsequent generations to produce new sets of solutions (chromosomes) through recombination and mutation
where the solutions with better fitness values have a higher chance to be there in the subsequent generation
so that the objective function is improved towards optimality.
To compute the MDPDE using GA, we consider the objective function Hn(θ) = Hn(µ, σ, γ) as the
fitness function with lower values indicating greater fitness of the solution vector Hn(θ = (µ, σ, γ). Then,
the algorithm traverses through the following steps.
GA for Computation of the MDPDE:
Step 1. We start with an initial set of N candidate solutions denoted as P(0) = {θ(0)1 ,θ(0)2 , ...,θ(0)N }. Set m = 0.
Step 2. Compute the fitness function Hn(θ) for each solutions in P(m) = {θ(m)1 ,θ(m)2 , ...,θ(m)N }.
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Step 3. From the set P(m), we choose some parent solutions to generate new solutions (offsprings) through
the ‘Fitness Proportionate Selection’ scheme, where the probability of selection is proportional to the
(better) fitness values.
Alternative schemes like ‘Roulette Wheel Selection’ or ‘Tournament Selection’ [43] can also be used.
Step 4. We form a new set of N candidate solutions, denoted as P(m+1) = {θ(m+1)1 ,θ(m+1)2 , ...,θ(m+1)N }, for
the next iteration (generation) using the following two steps:
Step 4.1. We choose a specific number (say NE) of elite solutions (survivor) from P(m) which are carried
forward over the next iteration (generation) without any alterations. They are again chosen by
the criterion of having best fitness values.
Step 4.2. For generating remaining (N−NE) candidate solutions for next generations, we perform crossover
and mutation operations (through some weighted combination) to the solutions from P(m) accord-
ing to some pre-specified crossover probability (PC) and mutation probability (PM ). The crossover
leads the solutions to a convergence while mutation increases diversity among the solutions to
avoid being stuck at a local optima.
Step 5. Set m = m+ 1 and go to Step 2.
Step 6. Repeat Step 2 to Step 5, until an appropriate (pre-specified) convergence criteria is satisfied.
When stopped, the fittest solution in the last iteration (generation) is returned as the optimal solution
(the MDPDE).
Note that, in order to implement the above G, we need to first specify the necessary tuning parameters
N,NE , PC ,MP ; it is suggestive to take NE as 5% of N , a higher value of PC and a lower values of PM for
faster convergence [40]. In all our numerical experiments (simulation studies), we have used the R package
‘GA’ to implement the Genetic Algorithm with N = 50, NE = 2, PM = 0.1, PC = 0.8 and a maximum of
5000 iterations (generations) as stopping criterion. However, one challenge using this approach is to choose
appropriate values of these tuning parameters for any real life application!
3.2 Gradient Descent Method
The method of gradient descent is another popular first-order iterative optimization algorithm mostly used
in Machine Learning [44, 45]. To find the minimum of the an objective function, this method progresses
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iteratively by updating the parameter values taking steps proportional to the negative of the gradient (first
order derivative) of the objective function. For choosing these steps in each iteration, there are various types
of algorithms available in the literature [46, 47]. It is important to note here that this gradient descent
approach might converge to just to a local minimum depending on the initial parameter value considered;
however, if the function is convex, which is mostly the case for our MDPDE, we expect to achieve the global
minimum by starting with any reasonable initial value.
Considering again the MDPDE objective function Hn(θ) = Hn(µ, σ, γ), the gradient descent algorithm
can be used to find its minimum, i.e., the required MDPDE, through the following steps:
Gradient Descent for Computation of the MDPDE:
Step 1. Start with an initial parameter value θ0=(µ0,σ0,γ0) and a step size (tuning parameter) λ > 0.
Set m = 0.
Step 2. Calculate ∇Hn(θm), the derivative of the function Hn(θ) with respect to θ evaluated at the point θm
(the solution at the mth step of iteration).
Step 3. Update the solution at (m+ 1)th step as: θm+1 = θm − λ∇Hn(θm).
Step 4. Set m = m+ 1 and go to Step 2.
Step 5. Repeat Step 2 to Step 4, until an appropriate convergence criteria is satisfied.
Here, we only need to choose one tuning parameter λ for the gradient descent algorithm and there exist
several suggestions for its optimum selection; see, e.e, [48, 49]. For all our numerical illustrations here,
we have taken λ=0.04, and the initial parameter value to be the maximum partial likelihood estimates of
θ = (µ, σ, γ), obtained by using the R function ‘sn.mple’, and the convergence criterion as no significant
(relative) change in the objective function. It has been observed through the extensive simulation studies that
both the gradient descent and genetic algorithm perform quite similarly for the computation of the MDPDE
under SN model, with the gradient descent taking significantly less computation time. Accordingly, the real
data applications are performed using gradient descent algorithm only.
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4 Robust Wald-type tests based on MDPDE
4.1 General Theory for Composite Hypotheses
We now consider the problem of testing statistical hypotheses. Suppose that, based on random sample
X1, . . . , Xn from the SN distribution, we want to test the composite hypothesis
H0 : θ ∈ Θ0 against H1 : θ /∈ Θ0, (12)
for some closed subset Θ0 of the parameter space Θ. In most applications, the restricted (null) parameter
space Θ0 is defined by a set of r ≤ 3 restrictions of the form m
(
θ
)
= 0r, where m : Θ 7→ Rr is a known
function. We assume that the 3× r matrix M(θ) = ∂mT (θ)∂θ exists, is continuous in θ and rank[M(θ)] = r.
The simplest possible case is Θ0 = {θ0} for some fixed θ0 = (µ0, σ0, γ0) ∈ Θ, where r = 3, m(θ) = θ − θ0
and M(θ) = I3, the identity matrix of order 3. Other common cases for the SN distribution could be
testing for one or two parameters (among three) considering the remaining parameter(s) as nuisance. As
noted earlier the usual test based on the MLE is non-robust and hence we discuss an Wald-type test based
on the robust MDPDEs following Basu et al. [33].
If θ̂α,n denote the MDPDE of θ based on the given sample, the Wald-type test statistic for testing the
hypothesis (12) is given by
Wα,n = nm
T
(
θ̂α,n
)[
MT
(
θ̂α,n
)
Σα
(
θ̂α,n
)
M
(
θ̂α,n
)]−1
m
(
θ̂α,n
)
, (13)
where Jα and Kα are as defined in (9) and (10), respectively. At α = 0, this Wald-type test statistics
coincides with the usual Wald test based on the MLE.
From the asymptotic distribution of the MDPDE θ̂α,n in Section 2.2, it immediately follows that Wα,n
asymptotically follows a (central) chi-squared distribution, χ2r, with r degrees of freedom under the null
hypothesis in (12). Therefore, we reject H0 in (12) at τ0 level of significance if Wα,n ≥ χ2r,τ0 , the upper
(1− τ0)-th quantile of χ2r distribution.
From the general theory of Basu et al. [33], the MDPDE based Wald-type test is consistent at any
fixed alternatives. Under the contiguous hypothesis of the form H1,n : θn = θ0 + n
−1/2d, with θ0 ∈
Θ0 and d ∈ R3 \ {03}, Wα,n asymptotically follows a non-central chi-squared distribution, denoted as
χ2r,δ, having r degrees of freedom and the non-centrality parameter δ = d
TQα
(
θ0
)
d, with Qα
(
θ0
)
=
15
M
(
θ0
)[
MT
(
θ0
)
Σα
(
θ0
)
M
(
θ0
)]−1
MT
(
θ0
)
. Based on this result, an approximate expression of contiguous
power function of the test based on Wα,n can be calculated as Πα
(
θn
)
= 1 − Gχ2r,δ
(
χ2r,τ0
)
, where Gχ2r,δ is
the cdf of the χ2r,δ distribution.
The robustness properties of the MDPDE based Wald-type tests were first discussed by [39] for general
parametric models, which also hold for our SN distribution case. For completeness, we restate the main
results briefly. At the null distribution with θ0 ∈ Θ0, the first order IF of the Wald-type test statistic is
inconclusive (identically zero) but the second order IF has the form
IF2
(
y,Wα,n,θ0
)
= 2IF
(
y, Tα,θ0
)T
Qα
(
θ0
)
IF
(
y, Tα,θ0
)
. (14)
Note that, this (second order) IF of the MDPDE based Wald-type test statistic directly depends on IF
(
y, Tα,θ0
)
,
the IF of the underlying MDPDE used. Based on our earlier exploration in Section 2.3, the test IF in (14)
will then be bounded in the contamination point y for any α > 0 which implies the robustness of the test
based on the MDPDE based statistics in (13).
Again from the general theory of [39], one can see the robustness of the level and power of the MDPDE
based Wald-type tests for any α > 0 through their bounded level influence function (LIF) and the power
influence function (PIF). In particular, the LIF of any order is identically zero and the PIF for testing at
the significance level τ0 has the form
PIF
(
y,Wα,n,θ0
)
= C∗r
(
dTQα
(
θ0
)
d
)
dTQα
(
θ0
)
IF (y, Tα,θ0), (15)
where C∗r
(
s
)
= e−
s
2
∑∞
v=0 s
v−12−v(2v − s)P (χ2r+2v > χ2r,τ0)/v!. Again the PIF is a linear function of the IF
of the MDPDE and hence bounded for all α > 0 indicating power robustness of the Wald-type test based
on (13).
4.2 Robust Test for Symmetry
We now discuss, in detail, a particular testing problem in the context of SN distribution, namely the test of
symmetry through the null hypothesis H0 : γ = 0. Let us consider a slightly general problem of testing
H0 : γ = γ0 against H1 : γ 6= γ0, (16)
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for a pre-fixed real γ0. Note that, the choice γ0 = 0 yields the test for symmetry against the SN alternatives.
Note that, here µ and σ are unknown nuisance parameters. In the notation of Section 4.1, we have Θ0 ={
θ = (µ, σ, γ)T : µ ∈ R, σ ∈ R+, γ = 0}, r = 1, m(θ) = γ − γ0 and M(θ) = (0, 0, 1)T .
Denoting the MDPDE as θ̂α,n =
(
µ̂α,n, σ̂α,n, γ̂α,n
)
, our MDPDE based Wald-type test statistics (13) has
a simplified form for testing (16) which is given by
Wα,n =
n (γ̂α,n − γ0)2
Σ
(33)
α (θ̂α,n)
, (17)
where Σ
(33)
α (θ) is the (3, 3)-th element of Σα(θ). Then, under the null hypothesis in (16), Wα,n asymptotically
follows χ21 distribution and the test can be performed by comparing Wα,n with the corresponding critical
values. Further, the approximate expression of power function at the contiguous hypothesis of the form
H1,n : γ = γ0 + n
−1/2d, with d ∈ R, is given by
Πα
(
θn
)
= 1−Gχ21,δ
(
χ21,τ0
)
, with δ =
d2
Σ
(33)
α (θ0)
, θ0 ∈ Θ0.
We have numerically calculated this asymptotic contiguous power for testing symmetry (γ0 = 0) at 5% level
of significance by the MDPDE based Wald-type test with different values of α, which are presented in Table
2 for θ0 = (0, 1, 0)
T . It is clear that, just like the ARE of the MDPDE, the contiguous power of the MDPDE
based test also decreases as α increases but this loss is not quite significant at small α > 0. For larger
values of d, i.e., alternatives further away from the null, the power eventually becomes one for all α ≥ 0 in
accordance with the consistency of these tests.
Table 2: Asymptotic contiguous power of the MDPDE based Wald-type test for testing symmetry (γ0 = 0)
at 5% level of significance with θ0 = (0, 1, 0)
T and different values of α and d
α
d 0 0.05 0.1 0.2 0.3 0.5 0.7 1
3.00 0.6685 0.6678 0.6662 0.6471 0.6327 0.6011 0.5507 0.4905
3.50 0.7982 0.7975 0.7960 0.7785 0.7649 0.7342 0.6827 0.6175
4.00 0.8915 0.8910 0.8899 0.8763 0.8655 0.8401 0.7948 0.7329
4.50 0.9489 0.9485 0.9478 0.9390 0.9317 0.9137 0.8792 0.8275
5.00 0.9790 0.9788 0.9784 0.9736 0.9694 0.9585 0.9356 0.8974
5.50 0.9925 0.9924 0.9922 0.9900 0.9879 0.9823 0.9690 0.9440
6.00 0.9977 0.9977 0.9976 0.9967 0.9958 0.9933 0.9866 0.9721
7.00 0.9999 0.9999 0.9998 0.9998 0.9997 0.9993 0.9982 0.9947
8.00 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.9998 0.9993
9.00 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 0.9999
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Next the robustness of the Wald-type test based on the statistic (17) for testing (16) can be studied
through the second order influence function of the test statistics and the PIF. From the general formulas
presented in Section 4.1, we can easily calculate these measures in the present case of testing (16) as given
by
IF2
(
y,Wα,n,θ0
)
= 2IF
(
y, T (γ)α ,θ0
)2
/Σ(33)α (θ0). (18)
PIF
(
y,Wα,n,θ0
)
= C∗r
(
d2/Σ(33)α (θ0)
)
IF (y, T (γ)α ,θ0)d/Σ
(33)
α (θ0), (19)
where T
(γ)
α is the MDPDE functional corresponding to γ and hence IF (y, T
(γ)
α ,θ0) is given by the third
component of the full 3-dimensional IF vector given in (11). For illustration, we have presented the plots
of these IF2 and PIF for different values of α at γ0 = 1, θ0 = (0, 1, 1)
T and d = 4 in Figure 4; note that
the plot of the corresponding IF (y, T
(γ)
α ,θ0) is as given in Figure 3c. It is clearly evident from these figures
that the MDPDE based Wald-type test statistic (17) has bounded second order IF as well as bounded PIF
for all α > 0 indicating the claimed robustness and the extent of robustness increases as α increases.
Figure 4: Second Order IF and the PIF for the MDPDE based of Wald-type test for testing γ = 1 with
θ0 = (0, 1, 1)
T and d = 4, for different α [blue solid line: α = 0 (MLE); dashed line: α = 0.1; dotted line:
α = 0.3; dash-dotted line: α = 0.5; black solid line: α = 1]
5 Simulation study
5.1 Performance of the MDPDE
We now examine the finite sample performances of the MDPDE for the SN distribution through a Monte-
Carlo simulation study. We simulate random samples from the SN distribution, using the R package ’Sn’,
for different sizes n = 50, 100, and the true parameter values (µ, σ, γ) = (0, 1, 5). Based on each simulated
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sample, we compute the MDPDEs at different α, including the MLE at α = 0, using the genetic algorithm
described in Section 3. Replicating this process 500 times, we compute the empirical bias and MSE of the
MDPDEs of the three parameters (µ, σ, γ) for the fitted SN distribution. Further, to examine the robustness
property, we repeat the above simulation exercise by contaminating 100% of each sample by observations
from a distant contaminating distribution. We have considered the contamination proportion  to be 0.05 and
0.1, leading to 5% and 10% contaminations respectively, and four different contaminating distributions as
SN(10,1,5), SN(−10,1,5), SN(0,5,5) and SN(0,1,1). For each situation, the bias and MSE under contaminated
data are again computed using 500 replications for MDPDEs at different α and are compared with their
pure data values. We report the exact values of the biases and MSEs of each of the three parameters (µ, σ, γ)
under each scenario in Table 4.
Table 3: Empirical Biases and MSEs of the MDPDEs for various α at sample size n = 50
α α
 0(MLE) 0.1 0.3 0.5 0.7 1 0(MLE) 0.1 0.3 0.5 0.7 1
Bias MSE
0 µ 0.009 0.015 0.017 0.023 0.050 0.100 0.006 0.008 0.010 0.012 0.019 0.028
σ -0.012 -0.086 -0.100 -0.112 -0.186 -0.253 0.008 0.017 0.023 0.040 0.096 0.118
γ 0.908 1.028 1.094 1.207 1.302 1.376 1.718 2.178 2.768 3.024 3.572 3.910
Outliers from SN(10,1,5)
0.05 µ 0.124 0.096 0.090 0.048 0.050 0.116 0.038 0.024 0.020 0.015 0.026 0.041
σ -0.316 -0.296 -0.177 -0.116 -0.170 -0.278 0.118 0.102 0.072 0.042 0.101 0.133
γ 1.229 1.169 1.088 0.992 1.276 1.398 3.745 3.272 3.129 3.049 3.802 4.172
0.1 µ 0.130 0.117 0.109 0.059 0.066 0.174 0.041 0.030 0.028 0.017 0.039 0.079
σ -0.373 -0.327 -0.226 -0.126 -0.177 -0.302 0.158 0.141 0.092 0.053 0.151 0.170
γ 1.411 1.338 1.185 1.070 1.342 1.446 3.958 3.573 3.385 3.128 3.990 4.360
Outliers from SN(-10,1,5)
0.05 µ -0.145 -0.098 -0.084 0.047 0.080 0.117 0.046 0.027 0.021 0.016 0.024 0.044
σ -0.272 -0.236 -0.121 -0.108 -0.178 -0.310 0.171 0.113 0.079 0.043 0.104 0.139
γ 1.217 1.138 1.081 0.961 1.192 1.368 3.698 3.240 3.119 3.029 3.598 4.062
0.1 µ -0.154 -0.114 -0.095 0.068 0.092 0.126 0.052 0.034 0.029 0.018 0.034 0.049
σ -0.327 -0.277 -0.122 -0.110 -0.182 -0.314 0.233 0.141 0.094 0.052 0.115 0.182
γ 1.285 1.149 1.093 1.008 1.230 1.425 3.786 3.470 3.218 3.096 3.996 4.281
Outliers from SN(0,5,5)
0.05 µ 0.090 0.079 0.064 0.063 0.086 0.122 0.036 0.024 0.019 0.014 0.023 0.029
σ 0.291 0.203 0.142 0.113 -0.170 -0.286 0.334 0.269 0.168 0.095 0.138 0.218
γ 1.270 1.126 1.058 0.971 1.265 1.316 3.841 3.259 3.134 2.977 3.635 4.014
0.1 µ 0.105 0.087 0.073 0.071 0.094 0.144 0.051 0.041 0.028 0.020 0.023 0.035
σ 0.336 0.298 0.151 -0.124 -0.214 -0.317 0.413 0.341 0.236 0.124 0.210 0.295
γ 1.324 1.168 1.094 1.003 1.337 1.409 3.927 3.478 3.197 3.086 3.942 4.388
Outliers from SN(0,1,1)
0.05 µ -0.072 -0.058 -0.043 0.036 0.080 0.122 0.094 0.040 0.021 0.014 0.022 0.031
σ -0.257 -0.171 -0.146 -0.115 0.168 0.292 0.225 0.197 0.133 0.073 0.108 0.164
γ 1.192 1.148 1.115 1.088 1.178 1.418 3.736 3.433 3.290 3.127 3.263 4.273
0.1 µ -0.091 -0.076 0.074 0.063 0.107 0.132 0.130 0.084 0.051 0.020 0.028 0.051
σ -0.299 -0.254 -0.192 0.150 0.187 0.325 0.332 0.245 0.140 0.089 0.124 0.195
γ 1.325 1.256 1.132 1.102 1.232 1.486 3.949 3.595 3.420 3.146 3.642 4.447
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Table 4: Empirical Biases and MSEs of the MDPDEs for various α at sample size n = 100
α α
 0(MLE) 0.1 0.3 0.5 0.7 1 0(MLE) 0.1 0.3 0.5 0.7 1
Bias MSE
0 µ 0.006 0.014 0.016 0.023 0.032 0.084 0.004 0.004 0.005 0.006 0.007 0.011
σ -0.004 -0.076 -0.091 -0.105 -0.154 -0.209 0.006 0.007 0.009 0.020 0.038 0.063
γ 0.495 0.563 0.781 1.016 1.142 1.201 0.912 1.182 1.334 2.193 3.020 3.223
Outliers from SN(10,1,5)
0.05 µ 0.102 0.087 0.060 0.024 0.042 0.095 0.028 0.020 0.016 0.008 0.014 0.034
σ -0.260 -0.223 -0.118 -0.105 -0.158 -0.215 0.098 0.064 0.049 0.027 0.100 0.130
γ 1.100 1.038 1.010 0.945 1.150 1.244 3.027 2.814 2.408 2.273 3.099 3.542
0.1 µ 0.103 0.089 0.064 0.028 0.050 0.105 0.032 0.022 0.018 0.010 0.016 0.042
σ -0.338 -0.257 -0.145 -0.109 -0.168 -0.258 0.141 0.092 0.066 0.035 0.116 0.150
γ 1.108 1.046 1.010 0.999 1.194 1.341 3.187 3.038 2.992 2.658 3.296 3.962
Outliers from SN(-10,1,5)
0.05 µ -0.126 -0.085 0.057 0.024 0.039 0.101 0.035 0.021 0.015 0.008 0.015 0.033
σ -0.221 -0.191 -0.115 -0.065 -0.167 -0.265 0.138 0.086 0.045 0.021 0.100 0.126
γ 1.132 1.044 1.011 0.955 1.163 1.229 3.353 2.881 2.390 2.274 3.091 3.296
0.1 µ -0.142 -0.096 -0.063 0.031 0.057 0.111 0.042 0.028 0.017 0.011 0.019 0.040
σ -0.275 -0.214 -0.119 -0.075 -0.173 -0.291 0.196 0.098 0.058 0.032 0.104 0.164
γ 1.187 1.096 1.072 0.986 1.189 1.260 3.598 3.072 2.890 2.580 3.458 3.911
Outliers from SN(0,5,5)
0.05 µ 0.070 0.064 0.053 0.047 0.085 0.108 0.018 0.010 0.009 0.006 0.010 0.018
σ 0.233 0.168 0.118 0.105 -0.147 -0.231 0.299 0.193 0.156 0.078 0.117 0.196
γ 1.168 1.051 1.007 0.861 1.154 1.206 3.164 2.881 2.465 2.243 3.172 3.805
0.1 µ 0.077 0.072 0.057 0.050 0.091 0.118 0.039 0.028 0.016 0.009 0.019 0.024
σ 0.264 0.240 0.136 0.117 0.184 -0.230 0.378 0.253 0.185 0.098 0.181 0.262
γ 1.235 1.100 1.069 0.974 1.270 1.349 3.499 3.132 2.987 2.567 3.580 4.068
Outliers from SN(0,1,1)
0.05 µ -0.057 -0.053 0.039 0.028 0.068 0.092 0.015 0.011 0.008 0.007 0.010 0.013
σ -0.194 -0.133 -0.124 0.113 0.126 0.216 0.166 0.103 0.090 0.044 0.062 0.133
γ 1.106 1.049 1.012 1.002 1.095 1.266 3.040 2.832 2.398 2.278 3.196 3.622
0.1 µ -0.065 -0.064 0.053 0.051 0.074 0.106 0.033 0.029 0.010 0.009 0.016 0.019
σ -0.256 -0.149 0.137 0.118 0.142 0.274 0.203 0.178 0.122 0.075 0.096 0.158
γ 1.230 1.188 1.087 1.020 1.130 1.292 3.391 3.098 2.781 2.398 3.305 4.010
One can clearly note that the bias and MSE under pure data increases with α but the increase is
reasonably smaller at smaller positive values of α. On the other hand, under contaminated data the bias
and MSE increases significantly for the MLE (at α = 0), whereas those for MDPDEs with larger α remains
more closer to their pure data values; the stability increases with increasing values of α > 0. Based on the
efficiency and robustness trade-off, it has been observed in all the situations considered, the MDPDE with
α around 0.5 produce smallest values of bias and MSEs under contamination which are significantly lower
compared to those obtained by the MLE under contamination.
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5.2 Performance of the MDPDE based Wald-type test
To visualize the performance of proposed MDPDE based Wald-type tests, we have again performed several
simulation studies. We consider the problem of testing symmetry through the hypothesis H0: γ = 0 against
H1: γ 6= 0, for which the Wald-type test statistic Wα,n is as given in (17) with γ0 = 0. We first simulate
random samples of sizes n = 50, 100 from the SN(0,1,0) distribution and perform the MDPDE based Wald-
type test for different α, including the classical Wald test at α = 0. Based on 500 replications, we then
compute the empirical levels of the tests measured as the proportion of test statistics exceeding the chi-
square critical value among the 500 replications. Subsequently, to compute the empirical power of the tests,
we repeat the above exercise but now generating random samples from an alternative SN(0,1,1) distribution.
Finally, to illustrate the claimed robustness, we recalculate the level and power of the Wald-type tests
after contamination 100% of each sample in the previous simulation exercises with  = 0.05, 0.1. The
contaminated observations are generated from SN(0,1,3) and SN(0,1,−3) distributions, (?????) respectively,
for the level and power calculations. In Table 5, we report all the resulting empirical levels and powers
obtained from different simulation scenarios.
Table 5: Empirical Levels and Powers of the MDPDE based Wald-type tests for different α
Sample α
Size (n)  0(MLE) 0.1 0.3 0.5 0.7 1.0
Level 50 0 0.12 0.144 0.162 0.188 0.22 0.25
0.05 0.796 0.44 0.25 0.194 0.168 0.126
0.10 0.848 0.486 0.282 0.216 0.184 0.14
100 0 0.058 0.102 0.124 0.168 0.18 0.202
0.05 0.862 0.52 0.264 0.19 0.134 0.116
0.10 0.876 0.55 0.296 0.202 0.148 0.124
Power 50 0 0.95 0.962 0.978 0.99 0.998 1.0
0.05 0.24 0.57 0.836 0.986 1 1
0.10 0.254 0.582 0.854 0.992 1 1
100 0 0.974 0.98 0.99 1 1 1
0.05 0.32 0.632 0.884 0.99 1 1
0.10 0.342 0.676 0.902 1 1 1
It can be observed from the table that, under pure data, the levels are inflated for Wald-type tests
with larger α. However, through more extensive simulations (not presented here for brevity) that the levels
stabilizes to the desired 5% significance level for larger sample sizes; although this happens for the classical
MLE based Wald test (at α = 0) at n = 100 itself, it needs much larger sample sizes to achieve desired
level for larger values of α. As a results, the pure data power always appears higher for the Wald-type
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tests with larger α and they indeed becomes one for all α at moderately large sample sizes. However, the
main advantage of the MDPDE based Wald-type tests appear at the stability of their levels and sizes under
contamination in sample data. For Wald test at α = 0, the level inflates significantly due to contamination but
becomes more stable with increasing α. Similarly, the power of the classical Wald test decreases drastically
under contamination but regain its high values for the MDPDE based Wald-type tests with larger α ≥ 0.3.
Therefore the MDPDE based Wald-type tests with moderately large α > 0 always produce more power with
a slightly inflated levels which remain stable even under different contamination levels.
6 Real Data Applications
6.1 AIS Dataset
Let us consider again the motivating dataset and use the MDPDE to obtain the estimates of the fitted SN
distributions. We consider again the important health indicator variables as in Figure 2 and compute the
MDPDEs of the parameters of the fitted SN distribution for each variable using the algorithm described in
Section 3. We have also estimated the standard errors of the resulting MDPDEs using the formula described
in Section 2.2. The parameter estimates, along with their standard errors, for all eight variables are reported
in Table 6. The outlier deleted MLE, obtained after removing the outliers identified through the respective
box-plots, are also presented in Table 6 for reference.
It can be easily observed from Table 6 that the MLE changes drastically for all the variables due to
the presence of outliers, but the proposed MDPDEs with larger α > 0 computed over the full data remain
extremely close to the outlier deleted MLE. Thus, the use of the MDPDEs with larger α > 0 leads to robust
insights even in the presence of outliers in the data; most of the time the MDPDEs with large values of
α are very close to the cleaned data MLE. However, we need larger values of α > 0 if the strength of the
outliers increases (more in number or greater distance from the data center) and vice versa. In the present
example, the variables HC, RCC and LBM all have one outlying data-point but the MDPDEs of RCC
and LBM becomes quite close to the outlier deleted MLE at α ≈ 0.1 and that requires larger α ≈ 0.5 for
HC due to the greater distance of the outlier in this case; among other variables PFC, having 12 outliers,
requires α ≈ 0.5 to generate robust estimates, whereas the corresponding values of α are 0.3 also for the
measurements BMI, WCC and Wt. In summary, all MDPDES with α ≥ 0.5 generates estimates similar to
the outlier deleted MLE in all cases although sometimes a substantially lower α > 0 may also produce stable
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Table 6: The SN parameter estimates (standard errors) for the measurements in AIS data, obtained through
MDPDEs at different α, the MLE (at α = 0) and the outlier deleted MLE. The number of outliers found
for each measurements are reported after their name in the first column.
Variable α Outlier deleted
(Outlier) 0(MLE) 0.1 0.3 0.5 0.7 1.0 MLE
HC µ 40.664 43.387 45.384 46.382 46.382 46.383 46.440
(1) (0.187) (0.339) (0.546) (0.670) (1.084) (1.463) (0.336)
σ 4.387 4.883 4.881 4.876 4.876 4.876 4.880
(0.185) (0.330) (0.438) (0.641) (1.300) (1.802) (0.333)
γ 0.966 -1.752 -1.762 -1.766 -1.766 -1.766 -1.794
(0.104) (0.472) (0.661) (0.942) (1.354) (1.979) (0.449)
RCC µ 4.296 4.543 4.539 4.525 4.528 4.529 4.543
(1) (0.020) (0.021) (0.022) (0.024) (0.027) (0.028) (0.018)
σ 0.622 0.525 0.530 0.504 0.521 0.533 0.466
(0.024) (0.026) (0.027) (0.028) (0.031) (0.035) (0.022)
γ 1.607 0.506 0.502 0.500 0.499 0.498 0.499
(0.086) (0.090) (0.095) (0.100) (0.107) (0.153) (0.086)
WCC µ 5.106 5.481 5.472 5.471 5.471 5.471 5.475
(4) (0.098) (0.099) (0.105) (0.106) (0.119) (0.156) (0.094)
σ 2.690 2.311 2.197 2.193 2.191 2.191 2.184
(0.105) (0.109) (0.125) (0.126) (0.147) (0.196) (0.099)
γ 2.727 1.716 1.712 1.712 1.712 1.712 1.703
(0.146) (0.164) (0.164) (0.166) (0.216) (0.250) (0.143)
PFC µ 20.244 23.197 23.196 23.196 23.196 23.196 23.226
(12) (1.519) (1.595) (1.742) (1.834) (1.977) (2.200) (1.546)
σ 73.840 67.835 61.832 57.832 57.832 57.832 57.671
(2.905) (3.178) (3.663) (3.689) (4.386) (4.868) (2.934)
γ 9.143 7.096 6.097 6.097 6.097 6.097 6.066
(0.361) (0.606) (0.628) (0.854) (1.097) (1.783) (0.402)
BMI µ 19.970 21.344 22.294 22.291 22.291 22.291 22.315
(7) (0.066) (0.067) (0.072) (0.077) (0.079) (0.169) (0.060)
σ 4.133 2.646 2.386 2.369 2.368 2.369 2.349
(0.125) (0.132) (0.136) (0.146) (0.159) (0.190) (0.117)
γ 2.313 1.227 0.595 0.194 0.195 0.194 0.174
(0.084) (0.087) (0.092) (0.096) (0.105) (0.216) (0.086)
LBM µ 50.383 50.953 50.953 50.953 50.953 50.953 50.958
(1) (0.765) (0.796) (0.801) (0.854) (0.959) (1.351) (0.768)
σ 19.493 18.726 18.727 18.726 18.726 18.726 18.718
(0.856) (0.886) (0.955) (1.124) (1.349) (1.978) (0.840)
γ 2.424 2.197 2.197 2.197 2.197 2.197 2.195
(0.106) (0.199) (0.199) (0.212) (0.229) (0.531) (0.106)
Ht µ 187.072 184.794 184.794 184.794 184.794 184.794 184.771
(3) (0.582) (0.612) (0.623) (0.647) (0.653) (1.095) (0.571)
σ 11.952 10.115 10.113 10.113 10.112 10.112 10.094
(0.321) (0.339) (0.384) (0.435) (0.517) (0.517) (0.315)
γ -1.074 -0.673 -0.676 -0.677 -0.678 -0.678 -0.674
(0.154) (0.166) (0.178) (0.185) (0.195) (0.284) (0.153)
Wt µ 64.066 69.063 72.063 72.063 72.063 72.062 72.143
(4) (0.378) (0.395) (0.416) (0.437) (0.495) (0.758) (0.373)
σ 17.682 14.076 13.072 13.071 13.071 13.071 13.024
(0.646) (0.686) (0.741) (0.748) (0.805) (0.874) (0.645)
γ 1.232 0.848 0.450 0.250 0.250 0.250 0.240
(0.085) (0.087) (0.092) (0.097) (0.104) (0.120) (0.085)
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results (like α = 0.1 for Ht).
To illustrate the robustness aspect of the MDPDEs more clearly, we have also recomputed the MDPDEs
for outlier deleted data for all α ≥ 0 and compared them with the corresponding full data values; the greater
robustness can be measured by the lower values of their relative differences defined as
RD(ν) =
|ν̂full − ν̂clean|
ν̂full
× 100%, ν ∈ {µ, σ, γ},
where ν̂full and ν̂clean denote, respectively, the estimates of ν ∈ {µ, σ, γ} obtained from full data with
outliers and the outlier deleted data. For all the eight measurements, the relative differences (RDs) of the
MDPDEs over different α are plotted in Figure 5. Clearly the RDs are significantly high for MLE (at α = 0);
they are as high as 1200% and 400% for the skewness parameter γ for BMI and Wt, respectively. But these
RDs decrease for MDPDEs as α > 0 increases and become very close to zero for α ≥ 0.5 in all the cases;
they already become close to zero at α ≈ 0.2 for HC, RCC, WCC, LBM and Ht. Among three parameters,
the effect of outliers is seen to be most significant for γ followed by σ and the effect is often minimum for
the parameter µ. All these illustrations clearly show the claimed robustness of the proposed MDPDE with
larger α > 0 for analyses of the present AIS dataset.
Next, let us study the performance of the proposed MDPDE based Wald-type tests for generating in-
ference for the present AIS data. We have examined several types of simple and composite parametric
hypotheses for different health measurements in AIS data with or without outliers. Since the results are
similar in all cases, for brevity, we report the six most interesting cases as follows. All six null hypotheses
are composite as we assume the other remaining parameters to be unknown under the null as well as the
corresponding omnibus alternative hypothesis.
Variable HC WCC LBM PFC BMI Wt
Hypothesis H0 γ = −1.8 γ = 1.7 γ = 2 σ = 57 σ = 4 µ = 72
For all these hypotheses, we have computed the p-values using the MDPDE based Wald-type tests for
different α for the full data as well as the outlier-deleted data, which are plotted in Figure 6. Note that, the
usual Wald test at α = 0 is strongly affected by the outliers and provides completely opposite inference with
clear difference in significance levels in presence or absence of outliers in most cases. However, the proposed
MDPDE based tests with α > 0 provides stable inference similar to the one we could have obtained after
removing the outliers for all the variables except PFC; for the testing problem in PFC, we need α ≥ 0.2 to
have robust inference due to the excessive amount of contamination. Another interesting case is the one with
24
(a) Hemoglobin Conc. (HC) (b) Red Cell Count (RCC)
(c) White Cell Count (WCC) (d) Plasma Fer. Conc. (PFC)
(e) Body Mass Index (BMI) (f) Lean Body Mass (LBM)
(g) Height (Ht) (h) Weight (Wt)
Figure 5: Relative differences (RDs) of the MDPDEs and MLE (at α = 0) due to the presence of outliers,
plotted over α, for different Health indicator variables from the AIS Data [Solid line: µ; dotted line: σ;
dashed line: γ]
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LBM, where the p-values obtained under the full data and outlier removed data are almost the same, except
for the classical Wald test at α = 0; the corresponding p-values obtained by Wald test are 0.000066 and
0.065, respectively. Thus, here also the inference at 95% significance level alters due to the outlier for Wald
tests, but the proposed MDPDE based tests at α > 0 yield more reasonable inference of failing to reject the
hypothesis even in the presence of outliers. These observations further support our claimed robustness of
the proposed MDPDE based Wald-type tests.
(a) Variable: HC; H0 : γ = −1.8 (b) Variable: WCC; H0 : γ = 1.7 (c) Variable: LBM; H0 : γ = 2
(d) Variable: PFC; H0 : σ = 57 (e) Variable: BMI; H0 : σ = 4 (f) Variable: Wt; H0 : µ = 72
Figure 6: P-values obtained for different hypotheses testing problems for AIS data using the MDPDE based
Wald-type tests for the full data (solid line) and the outlier-deleted data (dotted line).
6.2 AIDS Clinical Trial Data
Our second example is an AIDS clinical trial (ACTG 315) including 46 HIV-1 infected patients treated with
a potent antiretroviral drug cocktail based on protease inhibitor and reverse transcriptase drugs (ritonavir,
3TC and AZT). During the study, the viral load, cd4 count (CD4) and cd8 count (CD8) were measured
several times in different days from the start of the treatment (generally 4 to 10 measurements per patient)
The corresponding data has been analyzed by several statisticians [50–52] and is available in the R package
’qrNLMM ’. In particular Castro [6] fitted the skew-normal distribution to this data in a regression settings.
Here, we consider the variable CD4, CD8 and the logarithm of the viral load (LGVIRAL) measured at
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the second day after the start of the study for each patients. The corresponding histogram and the SN fit
by the MLE is presented in Figure 7; clearly the distributions are skewed but the MLE is unable to fit them
properly for CD8 and LGVIRAL due to the presence of outliers as shown in the respective box-plots in the
same figure (Figure 7). The MLE based fits are also shown in the figures along with the histogram, which
clearly show the inability of the MLE to adequately model the bulk of the data due to the presence of few
outlying points. In particular, the fitted SN distributions (by MLE) have a clearly different mode for both
the measurements CD8 and LGVIRAL due to strong outlier effects.
(a) CD4 (b) CD8 (c) LGVIRAL
Figure 7: Histograms and Box-plots of different variables, measured at day 2, from the ACTG 315 Data.
The SN distributions fitted by the MLE are also shown along with the histograms.
We next compute the proposed MDPDEs of the parameters of the fitted SN distribution for each of the
three health measurements and compared them with the MLEs and the outlier deleted MLEs; the resulting
estimates and their estimated standard errors are presented in Table 7. From the table, we can see that the
MDPDEs at any α > 0 are very similar to the MLE for CD4 where there are no outliers in the data. For
LGVIRAl, the MDPDEs with α ≥ 0.3 produce robust results which are significantly different from the MLE
and are close to the outlier deleted MLE. For CD8, however, the MDPDEs with α ≥ 0.1 are all similar but
significantly different from both the MLE as well as the outlier deleted MLE. To see which one provides the
more robust fit, in Figure 8, we have plotted the fitted SN density obtained by the MDPDE at α = 0.5,
the MLE and the outlier deleted MLE, along with the histograms of CD8 and LGVIRAL. In both cases,
the MDPDE seems to provide the best fit to the major bulk of the histogram, even better than the outlier
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deleted MLE. This shows that there are yet other masked outliers in the data which are not detectable by
the usual box-plot technique and hence illustrates the significance of our proposed MDPDEs over outlier
deletion methods in providing stable inference from contaminated data.
Table 7: The parameter estimates (standard errors) for the fitted SN distribution to the three health mea-
surements in AIDS clinical trail data (measured at day 2), obtained through MDPDEs at different α, the
MLE (at α = 0) and the outlier deleted MLE. The number of outliers found for each measurements are
reported after their name in the first column.
Variable α Outlier deleted
(Outlier) 0(MLE) 0.1 0.3 0.5 0.7 1.0 MLE
CD4 µ 252.650 252.634 252.634 252.634 252.634 252.634 252.650
(0) (1.538) (1.729) (1.954) (2.177) (2.280) (2.470) (1.538)
σ 89.204 89.204 89.204 89.204 89.204 89.204 89.204
(1.169) (1.243) (1.290) (1.343) (1.475) (1.989) (1.160)
γ -1.084 -1.057 -1.058 -1.059 -1.059 -1.059 -1.084
(0.675) (0.696) (0.733) (0.738) (0.752) (0.755) (0.679)
CD8 µ 407.251 407.141 407.140 407.140 407.140 407.140 408.972
(2) (1.605) (1.736) (1.804) (2.063) (2.160) (2.708) (1.284)
σ 757.601 594.563 594.562 594.562 594.562 594.562 570.614
(1.839) (2.297) (2.406) (2.749) (3.386) (3.986) (1.771)
γ 109.581 9.739 9.738 9.738 9.738 9.738 87.762
(1.291) (2.264) (2.370) (2.442) (2.751) (3.216) (0.790)
LGVIRAL µ 5.374 4.548 4.592 4.598 4.597 4.595 4.558
(1) (0.076) (0.076) (0.078) (0.086) (0.105) (0.278) (0.053)
σ 0.902 0.713 0.675 0.642 0.630 0.620 0.510
(0.076) (0.079) (0.085) (0.096) (0.117) (0.166) (0.055)
γ -1.231 1.222 1.271 1.380 1.485 1.609 1.679
(0.160) (0.305) (0.326) (0.330) (0.331) (0.927) (0.344)
(a) CD8 (b) LGVIRAL
Figure 8: The SN distributions fitted by the MDPDE at α = 0.5 (black dashed line), the MLE (blue
solid line) and the outlier deleted MLE (red dotted line), along with the histograms of the measurements
LGVIRAL and CD8 in AIDS clinical trial data.
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Finally, as in the previous example, here also we have observed that the MDPDEs with α ≥ 0.3 are
extremely stable in the presence and absence of the outliers, and produce robust inference for any parametric
hypothesis testing problem for these clinical trial data as well. So, we have not presented them here for
brevity.
7 Concluding remarks
In this paper, we have discussed new robust inference procedures for the SN distribution which is useful in
modeling noisy skewed data through the popular minimum DPD approach. The minimum DPD estimators
of the SN parameter are described along with their asymptotic and robustness properties and two efficient
computational algorithms have been proposed. Then, we discuss the robust testing procedure through the
MDPDE based Wald-type tests and their properties with detailed illustrations for testing symmetry against
SN alternatives. The usefulness of the SN distribution and the proposed robust inference in the context of
health data analysis are argued and illustrated empirically.
This work opens up several new directions in health research. The proposed methodology is a generaliza-
tion of the MLE which can be extended to different inferential problems in health studies with skewed data
to generate stable insight. For example, the immediate extension would be robust inference under regression
models for skewedly distributed responses or comparing different populations of skewed data. The latter can
be used in finding differential genes from expression data which are skewed in nature.
Although we have suggested some empirical choices for the tuning parameter α to be used in practice,
more detailed research in this line would be necessary to develop an algorithm for data-driven selection of
α; see, for example, [53]. We hope to pursue some of these extensions in our future work.
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